BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.3B
- YoY, 2025
- +5.0%
- 5-year CAGR
- +11.7%
- 10-year CAGR
- +4.8%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.3B | +5.0% |
| 2024 | $1.2B | +3.2% |
| 2023 | $1.2B | +8.1% |
| 2022 | $1.1B | +14.9% |
| 2021 | $973M | +29.2% |
| 2020 | $753M | −9.9% |
| 2019 | $836M | −12.1% |
| 2018 | $951M | −9.9% |
| 2017 | $1.1B | −13.2% |
| 2016 | $1.2B | +48.2% |
| 2015 | $820M | +55.9% |
| 2014 | $526M | −2.0% |
| 2013 | $537M | −2.0% |
| 2012 | $548M | +49.3% |
| 2011 | $367M | −13.4% |
| 2010 | $424M | −41.9% |
| 2009 | $730M | −22.4% |
| 2008 | $941M | +11.6% |
| 2007 | $843M | — |